Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pulmonary toxicity in patients treated with gemcitabine plus vinorelbine or docetaxel for advanced non-small cell lung cancer: outcome data on a randomized phase II study.
Esteban E, Villanueva N, Muñiz I, Fernández Y, Fra J, Luque M, Jiménez P, Llorente B, Capelan M, Vieitez JM, Estrada E, Buesa JM, Jiménez-Lacave A. Esteban E, et al. Among authors: llorente b. Invest New Drugs. 2008 Feb;26(1):67-74. doi: 10.1007/s10637-007-9073-4. Epub 2007 Sep 5. Invest New Drugs. 2008. PMID: 17805486 Clinical Trial.
Incidence of hand-foot syndrome with capecitabine in combination with chemotherapy as first-line treatment in patients with advanced and/or metastatic gastric cancer suitable for treatment with a fluoropyrimidine-based regimen.
Gómez-Martin C, Sánchez A, Irigoyen A, Llorente B, Pérez B, Serrano R, Safont MJ, Falcó E, Lacasta A, Reboredo M, Aparicio J, Dueñas R, Muñoz ML, Regueiro P, Sanchez-Viñes E, López RL. Gómez-Martin C, et al. Among authors: llorente b. Clin Transl Oncol. 2012 Sep;14(9):689-97. doi: 10.1007/s12094-012-0858-3. Epub 2012 Jul 19. Clin Transl Oncol. 2012. PMID: 22855151 Clinical Trial.
Lynch syndrome diagnostics: decision-making process for germ-line testing.
Lastra E, García-González M, Llorente B, Bernuy C, Barrio MJ, Pérez-Cabornero L, Durán M, García-Girón C. Lastra E, et al. Among authors: llorente b. Clin Transl Oncol. 2012 Apr;14(4):254-62. doi: 10.1007/s12094-012-0793-3. Clin Transl Oncol. 2012. PMID: 22484632 Review.
Dynamic soluble changes in sVEGFR1, HGF, and VEGF promote chemotherapy and bevacizumab resistance: A prospective translational study in the BECOX (GEMCAD 09-01) trial.
Pineda E, Salud A, Vila-Navarro E, Safont MJ, Llorente B, Aparicio J, Vera R, Escudero P, Casado E, Bosch C, Bohn U, Pérez-Carrión R, Carmona A, Ayuso JR, Ripollés T, Bouzas R, Gironella M, García-Albéniz X, Feliu J, Maurel J. Pineda E, et al. Among authors: llorente b. Tumour Biol. 2017 Jun;39(6):1010428317705509. doi: 10.1177/1010428317705509. Tumour Biol. 2017. PMID: 28621236 Free article. Clinical Trial.
[Diagnostic protocol for chronic manifestations of COVID-19].
Llorente BC, López AMC, Sánchez RH, Gutiérrez CH. Llorente BC, et al. Medicine (Madr). 2022 May;13(55):3256-3260. doi: 10.1016/j.med.2022.05.007. Epub 2022 May 12. Medicine (Madr). 2022. PMID: 35582695 Free PMC article. Spanish.
Absence of chromosome axis protein recruitment prevents meiotic recombination chromosome-wide in the budding yeast Lachancea kluyveri.
Legrand S, Saifudeen A, Bordelet H, Vernerey J, Guille A, Bignaud A, Thierry A, Acquaviva L, Gaudin M, Sanchez A, Johnson D, Friedrich A, Schacherer J, Neale MJ, Borde V, Koszul R, Llorente B. Legrand S, et al. Among authors: llorente b. Proc Natl Acad Sci U S A. 2024 Mar 19;121(12):e2312820121. doi: 10.1073/pnas.2312820121. Epub 2024 Mar 13. Proc Natl Acad Sci U S A. 2024. PMID: 38478689
118 results